U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 213

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr14:35873823
GRCh38:
Chr14:35404617
NFKBIAE10*Ectodermal dysplasia and immunodeficiency 2Pathogeniccriteria provided, single submitter
2.
GRCh37:
Chr14:35182071-35873850
BAZ1A, CFL2, FAM177A1, NFKBIA, PPP2R3C, PRORP, PSMA6, SRP54not provided, Ectodermal dysplasia and immunodeficiency 2Uncertain significance
(Jul 19, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr14:35872048
GRCh38:
Chr14:35402842
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jul 11, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr14:35872922
GRCh38:
Chr14:35403716
NFKBIAL104FEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Jun 25, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr14:35872484
GRCh38:
Chr14:35403278
NFKBIAR140PEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Sep 5, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr14:35872378
GRCh38:
Chr14:35403172
NFKBIAI175MEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Jun 15, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr14:35872032
GRCh38:
Chr14:35402826
NFKBIAG194DEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Jul 5, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr14:35873807
GRCh38:
Chr14:35404601
NFKBIAG15DEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Oct 12, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr14:35871680
GRCh38:
Chr14:35402474
NFKBIAN276DEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Jul 30, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr14:35872345
GRCh38:
Chr14:35403139
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Aug 5, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr14:35872892
GRCh38:
Chr14:35403686
NFKBIAEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 10, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr14:35873832
GRCh38:
Chr14:35404626
NFKBIAR7CEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Oct 9, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr14:35871883
GRCh38:
Chr14:35402677
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Sep 15, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr14:35871962
GRCh38:
Chr14:35402756
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jan 3, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr14:35873824
GRCh38:
Chr14:35404618
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Mar 26, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr14:35871973
GRCh38:
Chr14:35402767
NFKBIAEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Sep 28, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr14:35871602
GRCh38:
Chr14:35402396
NFKBIAE302KEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Apr 15, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr14:35871658
GRCh38:
Chr14:35402452
NFKBIAS283NInborn genetic diseases, Ectodermal dysplasia and immunodeficiency 2Uncertain significance
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr14:35872394
GRCh38:
Chr14:35403188
NFKBIAP170LEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Oct 8, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr14:35871754
GRCh38:
Chr14:35402548
NFKBIAY251CEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Sep 29, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr14:35872425
GRCh38:
Chr14:35403219
NFKBIAV160LEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 11, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr14:35873619
GRCh38:
Chr14:35404413
NFKBIAEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Mar 18, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr14:35871756
GRCh38:
Chr14:35402550
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Mar 17, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr14:35872889
GRCh38:
Chr14:35403683
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Mar 1, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr14:35872430
GRCh38:
Chr14:35403224
NFKBIAA158VEctodermal dysplasia and immunodeficiency 2Uncertain significance
(May 13, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr14:35871818
GRCh38:
Chr14:35402612
NFKBIAP230AEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 15, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr14:35872021
GRCh38:
Chr14:35402815
NFKBIAI198VEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Mar 2, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr14:35872493
GRCh38:
Chr14:35403287
NFKBIAP137fsEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Feb 11, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr14:35872367
GRCh38:
Chr14:35403161
NFKBIAT179IEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Jan 16, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr14:35872475
GRCh38:
Chr14:35403269
NFKBIAR143QEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 21, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr14:35872397
GRCh38:
Chr14:35403191
NFKBIAT169IEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 24, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr14:35871272
GRCh38:
Chr14:35402066
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Dec 13, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr14:35871644
GRCh38:
Chr14:35402438
NFKBIAS288GEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Oct 4, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr14:35873700
GRCh38:
Chr14:35404494
NFKBIAE51KEctodermal dysplasia and immunodeficiency 2Benign
(Aug 16, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr14:35873607
GRCh38:
Chr14:35404401
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Aug 3, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr14:35871261
GRCh38:
Chr14:35402055
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jun 13, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr14:35872487
GRCh38:
Chr14:35403281
NFKBIAL139REctodermal dysplasia and immunodeficiency 2Uncertain significance
(Jun 8, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr14:35873833
GRCh38:
Chr14:35404627
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(May 12, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr14:35872950
GRCh38:
Chr14:35403744
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Nov 1, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr14:35873801
GRCh38:
Chr14:35404595
NFKBIAR17HEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr14:35872394
GRCh38:
Chr14:35403188
NFKBIAP170REctodermal dysplasia and immunodeficiency 2Benign
(Nov 1, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr14:35871765
GRCh38:
Chr14:35402559
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Oct 4, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr14:35872487
GRCh38:
Chr14:35403281
NFKBIAL139PEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Feb 23, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr14:35871645
GRCh38:
Chr14:35402439
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Oct 17, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr14:35872371
GRCh38:
Chr14:35403165
NFKBIAA178TEctodermal dysplasia and immunodeficiency 2, Inborn genetic diseasesUncertain significance
(Sep 16, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr14:35872041
GRCh38:
Chr14:35402835
NFKBIAS191CEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Oct 19, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr14:35871256
GRCh38:
Chr14:35402050
NFKBIAD306GEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Sep 26, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr14:35873733
GRCh38:
Chr14:35404527
NFKBIAE40KEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Sep 2, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr14:35873805
GRCh38:
Chr14:35404599
NFKBIAP16AEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 1, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr14:35871664
GRCh38:
Chr14:35402458
NFKBIAP281LEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Jul 27, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr14:35872416
GRCh38:
Chr14:35403210
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jan 28, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr14:35871610-35871621
GRCh38:
Chr14:35402404-35402415
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jul 24, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr14:35871618
GRCh38:
Chr14:35402412
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jul 1, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr14:35872338
GRCh38:
Chr14:35403132
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Oct 4, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr14:35872935
GRCh38:
Chr14:35403729
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jul 29, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr14:35872399
GRCh38:
Chr14:35403193
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Aug 23, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr14:35872462
GRCh38:
Chr14:35403256
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Sep 7, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr14:35871957
GRCh38:
Chr14:35402751
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Mar 23, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr14:35872082
GRCh38:
Chr14:35402876
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jun 20, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr14:35871640
GRCh38:
Chr14:35402434
NFKBIAY289CEctodermal dysplasia and immunodeficiency 2Benign
(Feb 5, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr14:35871986
GRCh38:
Chr14:35402780
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Aug 22, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr14:35871837
GRCh38:
Chr14:35402631
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jul 6, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr14:35871581
GRCh38:
Chr14:35402375
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(May 27, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr14:35872426
GRCh38:
Chr14:35403220
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Mar 19, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr14:35872876
GRCh38:
Chr14:35403670
NFKBIAEctodermal dysplasia and immunodeficiency 2Benign
(Feb 4, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr14:35872967
GRCh38:
Chr14:35403761
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Mar 29, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr14:35871225
GRCh38:
Chr14:35402019
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Aug 9, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr14:35872581
GRCh38:
Chr14:35403375
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Mar 19, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr14:35873012
GRCh38:
Chr14:35403806
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jul 12, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr14:35872904
GRCh38:
Chr14:35403698
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Feb 4, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr14:35873806
GRCh38:
Chr14:35404600
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Aug 19, 2021)
criteria provided, single submitter
72.
GRCh37:
Chr14:35872877
GRCh38:
Chr14:35403671
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jun 6, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr14:35871584
GRCh38:
Chr14:35402378
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jun 13, 2021)
criteria provided, single submitter
74.
GRCh37:
Chr14:35871280-35871281
GRCh38:
Chr14:35402074-35402075
NFKBIAEctodermal dysplasia and immunodeficiency 2Benign
(Sep 1, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr14:35872500
GRCh38:
Chr14:35403294
NFKBIAC135GEctodermal dysplasia and immunodeficiency 2Likely benign
(Feb 5, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr14:35872880
GRCh38:
Chr14:35403674
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Nov 1, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr14:35871958
GRCh38:
Chr14:35402752
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Sep 18, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr14:35872438
GRCh38:
Chr14:35403232
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Jul 28, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr14:35872070
GRCh38:
Chr14:35402864
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Feb 2, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr14:35872912
GRCh38:
Chr14:35403706
NFKBIAQ107REctodermal dysplasia and immunodeficiency 2Uncertain significance
(Oct 20, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr14:35872976
GRCh38:
Chr14:35403770
NFKBIAE86KEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Nov 5, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr14:35871229
GRCh38:
Chr14:35402023
NFKBIAL315RInborn genetic diseases, Ectodermal dysplasia and immunodeficiency 2Uncertain significance
(Nov 21, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr14:35871745
GRCh38:
Chr14:35402539
NFKBIAY254CEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Jul 26, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr14:35872945
GRCh38:
Chr14:35403739
NFKBIAQ96Rnot provided, Ectodermal dysplasia and immunodeficiency 2Uncertain significance
(Dec 12, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr14:35871625
GRCh38:
Chr14:35402419
NFKBIAE294GEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Mar 11, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr14:35871722
GRCh38:
Chr14:35402516
NFKBIAS262GEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Mar 19, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr14:35873774
GRCh38:
Chr14:35404568
NFKBIAL26REctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr14:35872044
GRCh38:
Chr14:35402838
NFKBIAA190VEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Feb 4, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr14:35872962
GRCh38:
Chr14:35403756
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Aug 22, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr14:35871619
GRCh38:
Chr14:35402413
NFKBIAT296MEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr14:35872992
GRCh38:
Chr14:35403786
NFKBIAEctodermal dysplasia and immunodeficiency 2Likely benign
(Aug 23, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr14:35873796
GRCh38:
Chr14:35404590
NFKBIAG19REctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr14:35872907
GRCh38:
Chr14:35403701
NFKBIAN109HEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 7, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr14:35871764
GRCh38:
Chr14:35402558
NFKBIAY248HEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 30, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr14:35872036
GRCh38:
Chr14:35402830
NFKBIAH193NEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Sep 10, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr14:35872563
GRCh38:
Chr14:35403357
NFKBIAP114AEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Oct 15, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr14:35873785-35873787
GRCh38:
Chr14:35404579-35404581
NFKBIAK22delEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Jul 12, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr14:35873658
GRCh38:
Chr14:35404452
NFKBIAP65AEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Feb 10, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr14:35873840
GRCh38:
Chr14:35404634
NFKBIAA4VEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Feb 2, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr14:35872948
GRCh38:
Chr14:35403742
NFKBIAR95PEctodermal dysplasia and immunodeficiency 2Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination